Supernus Pharmaceuticals (SUPN) Return on Invested Capital (2015 - 2025)

Supernus Pharmaceuticals (SUPN) has 11 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital fell to 0.0% in Q4 2025 per SUPN's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q1 2021 and troughed at 0.0% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
• A 5-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then slumped by 31 bps to 0.0% in 2022, then plunged by 106 bps to 0.0% in 2023, then surged by 2517 bps to 0.0% in 2024, then plunged by 179 bps to 0.0% in 2025.
• Business Quant data shows SUPN's Return on Invested Capital at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.0% in Q2 2025.